ID Source | ID |
---|---|
PubMed CID | 8196 |
CHEMBL ID | 1867205 |
SCHEMBL ID | 434543 |
MeSH ID | M0187492 |
Synonym |
---|
butyl carbitol rhodanate |
thiocyanic acid, 2-(2-butoxyethoxy)ethyl ester |
butoxyrhodanodiethyl ether |
1-butoxy-2-(2-thiocyanoethoxy)ethane |
ethane, 1-butoxy-2-(2-thiocyanatoethoxy)- |
nsc3534 |
.beta.-butoxy-.beta.'-thiocyanodiethyl ether |
2-(2-butoxyethoxy)ethyl thiocyanate |
wln: ncs2o2o4 |
lethane |
2-[2-(butoxy)ethoxy]ethyl thiocyanic acid ester |
lethane 384 special (use 2 code nos. 010002 and 010101) |
ethanol, thiocyanate |
nsc-3534 |
2-butoxy-2'-thiocyanodiethyl ether |
lethane 384 |
112-56-1 |
ent 6 |
butyl carbitol thiocyanate |
NCGC00091820-01 |
ccris 5986 |
2-(2-butoxyethoxy)ethylthiokyanat [czech] |
1-butoxy-alpha-(2-thiocyanoethoxy)ethane |
2-(2-butoxyethoxy)ethylthiocyanate |
2-(2-(butoxy)ethoxy)ethyl thiocyanic acid ester |
ai3-00006 |
ethanol, 2-(2-butoxyethoxy)-, thiocyanate |
caswell no. 084 |
beta-butoxy-beta'-thiocyano diethyl ether |
beta-butoxy-beta'-thiocyanodiethyl ether |
2-(2-(butoxy)ethoxy) ester of thiocyanic acid |
lethane 384 regular |
nsc 3534 |
brn 1812307 |
2-(2-butoxyethoxy)ethyl ester of thiocyanic acid |
hsdb 1517 |
einecs 203-985-7 |
beta-butoxy beta'-thiocyano diethyl ether |
epa pesticide chemical code 010002 |
NCGC00091820-02 |
2-(2-butoxyethoxy)ethylthiokyanat |
unii-z8anl9b54i |
z8anl9b54i , |
dtxsid6024674 , |
tox21_303547 |
dtxcid304674 |
NCGC00257458-01 |
cas-112-56-1 |
NCGC00258869-01 |
tox21_201317 |
AKOS024332353 |
thiocyanic acid,2-(2-butoxyethoxy)ethyl ester |
SCHEMBL434543 |
diethylene glycol monobutyl ether thiocyanate |
lethane 384 [mi] |
ent-6 |
lethane 384 [hsdb] |
1-butoxy-.alpha.-(2-thiocyanoethoxy)ethane |
JVGPVVUTUMQJKL-UHFFFAOYSA-N |
CHEMBL1867205 |
2-[2-butoxyethoxy]ethyl thiocyanate |
1-(2-(2-thiocyanatoethoxy)ethoxy)butane |
FT-0711425 |
2-[2-butoxyethoxy]ethylthiocyanate |
Q27295138 |
1-butoxy-2-[2-(cyanosulfanyl)ethoxy]ethane |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
interleukin 8 | Homo sapiens (human) | Potency | 47.3079 | 0.0473 | 49.4806 | 74.9780 | AID651758 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 0.8482 | 0.0007 | 14.5928 | 83.7951 | AID1259369 |
AR protein | Homo sapiens (human) | Potency | 27.4075 | 0.0002 | 21.2231 | 8,912.5098 | AID743063 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 0.5623 | 0.0002 | 14.3764 | 60.0339 | AID588532 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 29.0314 | 0.0008 | 17.5051 | 59.3239 | AID1159531 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 51.1865 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 29.5598 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 23.0865 | 0.0010 | 19.4141 | 70.9645 | AID588537; AID743191 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 2.5654 | 0.0003 | 23.4451 | 159.6830 | AID743065 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.39) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |